Form D · Pharmaceuticals

Verndari, Inc.

Napa, CA · CIK 0001665277

Offering snapshot reported Feb 3, 2017 · SEC filing

Reported sold
$1.59M
Offering amount: $2M
Investors reported
19
Form D · investor count
Minimum accepted
$1
Reported outside-investor minimum
First sale
Jan 22, 2016
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$793K$1.59MFeb 2, 2016: $300,000.00Feb 2, 2016Feb 2, 2017: $1,385,000.00Feb 3, 2017: $1,585,000.00Feb 3, 2017

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,385,000 → $1,585,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 3, 2017Amendment$1,585,000$200,000vs Feb 2, 201719SEC filing
Feb 2, 2017Amendment$1,385,000$1,085,000vs Feb 2, 201619SEC filing
Feb 2, 2016Initial$300,000No comparison3SEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-256517

Source: Form D, filed Feb 3, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John H. Brown Executive
Daniel R. Henderson Director, Executive
Jan A. Van Prooyen Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
1564 Milton Road
Napa, CA, 94559